Cargando…

Assessment of pulmonary surfactant in COVID-19 patients

Detalles Bibliográficos
Autores principales: Schousboe, Peter, Wiese, Lothar, Heiring, Christian, Verder, Henrik, Poorisrisak, Porntiva, Verder, Povl, Nielsen, Henning Bay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7475719/
https://www.ncbi.nlm.nih.gov/pubmed/32894160
http://dx.doi.org/10.1186/s13054-020-03268-9
_version_ 1783579569394024448
author Schousboe, Peter
Wiese, Lothar
Heiring, Christian
Verder, Henrik
Poorisrisak, Porntiva
Verder, Povl
Nielsen, Henning Bay
author_facet Schousboe, Peter
Wiese, Lothar
Heiring, Christian
Verder, Henrik
Poorisrisak, Porntiva
Verder, Povl
Nielsen, Henning Bay
author_sort Schousboe, Peter
collection PubMed
description
format Online
Article
Text
id pubmed-7475719
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-74757192020-09-08 Assessment of pulmonary surfactant in COVID-19 patients Schousboe, Peter Wiese, Lothar Heiring, Christian Verder, Henrik Poorisrisak, Porntiva Verder, Povl Nielsen, Henning Bay Crit Care Letter BioMed Central 2020-09-07 /pmc/articles/PMC7475719/ /pubmed/32894160 http://dx.doi.org/10.1186/s13054-020-03268-9 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Letter
Schousboe, Peter
Wiese, Lothar
Heiring, Christian
Verder, Henrik
Poorisrisak, Porntiva
Verder, Povl
Nielsen, Henning Bay
Assessment of pulmonary surfactant in COVID-19 patients
title Assessment of pulmonary surfactant in COVID-19 patients
title_full Assessment of pulmonary surfactant in COVID-19 patients
title_fullStr Assessment of pulmonary surfactant in COVID-19 patients
title_full_unstemmed Assessment of pulmonary surfactant in COVID-19 patients
title_short Assessment of pulmonary surfactant in COVID-19 patients
title_sort assessment of pulmonary surfactant in covid-19 patients
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7475719/
https://www.ncbi.nlm.nih.gov/pubmed/32894160
http://dx.doi.org/10.1186/s13054-020-03268-9
work_keys_str_mv AT schousboepeter assessmentofpulmonarysurfactantincovid19patients
AT wieselothar assessmentofpulmonarysurfactantincovid19patients
AT heiringchristian assessmentofpulmonarysurfactantincovid19patients
AT verderhenrik assessmentofpulmonarysurfactantincovid19patients
AT poorisrisakporntiva assessmentofpulmonarysurfactantincovid19patients
AT verderpovl assessmentofpulmonarysurfactantincovid19patients
AT nielsenhenningbay assessmentofpulmonarysurfactantincovid19patients